The hope is to give customers a choice of how they want to use it: either via smartphone app, or a separate receiver device. We’ll be running this pivotal study in 2020, and the launch will be sometime in 2021. While we don’t expect to see this launched in 2020, we do expect to hear updates on development and early trials. Tandem will be rolling it out starting in mid-January 2020, along with a new mobile app that will enable auto-uploads of diabetes device data to its t:connect web platform. “I am not going to provide you a specific clinical trial, filing and launch dates today,” Sayer told analysts, adding, “we have no interest in sharing our playbook with the entire industry.”. Though more recently, we’re hearing Bigfoot plans to file the Unity pen-version in late 2020 with a possible launch slated for end of the year, so we shall see. September 9, 2019 08:00 AM PDT Dexcom G6® CGM System Now Available In Canada DiabetesMine reports on future CGM devices from Ascensia Diabetes and WaveForm Diabetes, on the heels of the 2019 JP Morgan Healthcare conference. The t:sport will have a stick-to-your-body adhesive part on the back, but would detach and also the t:slim’s trademark pigtail insulin tubing that attaches to the infusion set for insulin delivery. Lilly also tells us that at the upcoming ATTD conference happening in Madrid in late February, they’ll present research on “a potential mobile app that would provide personalized proactive guidance… around exercise.” That will be part of their “larger Connected Care program.”. In an earnings call in August 2019, BD announced it had withdrawn its FDA application for this product, but then-CEO Victor Forlenza (who was replaced in Sept. 2019) still emphasized that BD was working on it with a third-party R&D partner and “remained committed” to the patch pump. As for making CGMs in hospitals a permanent fixture even if COVID-19 dies down, Dexcom has not yet had any additional discussions with the FDA, but plans to. Differences between the Dexcom G6 and G7. Second quarter sales approached $452 million, or around $35 million ahead of analyst expectations. * *If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. We’re excited to see an “official” version of this system with potential smartphone mobile app control hopefully coming soon this year. FCC ID application submitted by Dexcom, Inc. for G6 Transmitter for FCC ID PH29588 ( PH2 9588 ) User Manual, Frequency, Reports, Images and more. After disclosing last quarter that coronavirus-driven delays of at least six months will affect pivotal studies of its G7 device, CEO Kevin Sayer told investors Tuesday it will forgo an end of 2020 soft launch and wait to roll it out until the company has the capacity to fully transition G6 users to the new technology. Software … And so, we’re going to make sure everyone has access at launch. The Autonomy pump-based system is slated to follow, possibly in 2023. After disclosing last quarter that coronavirus-driven delays of at least six months will affect pivotal studies of its G7 device, CEO Kevin Sayer told investors Tuesday it will forgo an end of 2020 soft launch and wait to roll it out until the company has the capacity to fully transition G6 users to the new technology. We’ve heard the holdup has been the FDA considering whether to grant this device the new “iCGM” designation, that would deem it officially interoperable with other such devices, like the Tandem t:slim X2. A slew of smartwatches let people with diabetes monitor blood sugars from their wrist. The Dexcom G6 is FDA-permitted for people with Type 1 and Type 2 Diabetes to make diabetes treatment decisions with zero fingersticks and no calibration. Eventually, this will work with the Dexcom CGM (continuous glucose monitor), as the two companies just signed an agreement to that end. And now that we’ve been through this initial wave of learning, we'll probably get better data and more data and know what we're looking for going forward," Sayer said. DiabetesMine shares its monthly list of favorite social media posts for December 2020. Of course, all of the above innovations mean nothing if people can’t afford or get their hands on them. The Libre 2.0 will bring optional alerts via Bluetooth Low Energy (BLE) that alarm if you’re out of range, to prompt you to do a fingerstick check to confirm an actual Low or High reading. Real-Time Glucose Readings, Right on Your Smart Device. Of course, the company is also working to address the server outage problems that came up twice in 2019 — once over the 2018-2019 new year holiday and a longer stretch over the Thanksgiving 2019 holiday weekend. Back; Dexcom G6 Intro; How to Restart A Dexcom G6; ... Back; My 10 Day Dexcom Rash Test; How to Quickly Release The Dexcom G6 Transmitter; Dexcom Downloads; T1 - T2 Facebook Groups; Dexcom G7 On The Horizen! Moving forward, Dexcom plans to offer the same hardware for different groups of its customers, differentiating the sensor via software/apps. Sayer said design of G7 is complete and access to clinics has reopened, but was tightlipped on other fronts. 2nd March 2017. The Keys are automatically updated daily. Blackford told analysts spending will rise significantly in the second half of the year, about $100 million more, not just from advertising costs but from resources toward G7 studies, for which the company is currently finalizing locations and timing both in the U.S. and internationally.